Honasa Consumer buys 58% stake in Fluence Pharma for ₹135 crore
Published on: June 24, 2026, 2 a.m. | Source: scanx.trade
Honasa Consumer Limited has approved the acquisition of a 58% equity stake in Fluence Pharma Private Limited for an enterprise value of approximately ₹135 crore, marking its entry into the nutraceuticals sector. The transaction, approved on June 23, 2026, involves a secondary share purchase and includes an option to acquire the remaining 42% stake over the next 5-7 years. Concurrently, Honasa Consumer approved the incorporation of a wholly-owned subsidiary, Honasa Health Private Limited, to undertake B2C operations for the nutraceuticals business.
